Our latest Investing Matters Podcast episode with QuotedData's Edward Marten has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrimson Tide Regulatory News (TIDE)

Share Price Information for Crimson Tide (TIDE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 160.00
Bid: 155.00
Ask: 165.00
Change: 0.00 (0.00%)
Spread: 10.00 (6.452%)
Open: 160.00
High: 160.00
Low: 160.00
Prev. Close: 160.00
TIDE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proposed Reconstruction of Capital

30 Dec 2015 07:00

RNS Number : 3637K
Crimson Tide PLC
30 December 2015
 

 

CRIMSON TIDE PLC

 

("Crimson Tide" or "the Company")

 

Proposed Reconstruction of capital

 

PROPOSED AUTHORITY FOR THE PURCHASE OF NEW ORDINARY SHARES BY THE COMPANY

 

PROPOSED ADOPTION OF NEW ARTICLES OF ASSOCIATION

 

AND

 

NOTICE OF GENERAL MEETING

 

Crimson Tide announces that it has commenced the process of seeking shareholder approval to undergo a capital reconstruction and has called a General Meeting. The purpose of this reconstruction is to create positive retained earnings in the Balance Sheet to allow the Company to, if appropriate, pay dividends in the future. The Company will also be seeking shareholder approval for share buy backs and will be eliminating its deferred shares.

 

A notice convening the General Meeting has today been mailed to shareholders. The General Meeting will be held at the offices of Shipleys LLP at 10 Orange Street, Haymarket, London, WC2H 7DQ on 26 January 2016 at 11.30 a.m. The Notice of General Meeting and Circular is available for inspection at the Company's website at www.crimsontide.co.uk.

 

Barrie Whipp, Executive Chairman, said "Considering the Company's recent performance, we have decided to undertake this exercise which will, at the discretion of the Directors, allow dividends to be considered for the first time since we came to AIM. Coupled with the elimination of the Deferred Shares (a relic from the company we reversed into when coming to AIM) and the ability for the company to, if appropriate, buy back shares the Company's Balance Sheet will be regularised and robust "

 

For further information, please contact:

 

Crimson Tide plc

 Barrie Whipp 01892 542444

 Steve Goodwin

 

W.H. Ireland Limited

 James Joyce / 020 7220 1666

 James Bavister

 

Background and reasons for the REDUCTION OF CAPITAL

The Companies Act 2006 only permits a company to make distributions to its shareholders out of its profits available for that purpose. In addition, a public company may fund a purchase of its own shares out of distributable profits. Such profits are, broadly, a company's accumulated realised profits so far as not previously utilised by distribution or capitalisation, less its accumulated realised losses.

As at 31 December 2014, the Company had an accumulated deficit on its profit and loss account of £4.069 million and there was £1.09 million standing to the credit of the Company's share premium account and £49,000 standing to the credit of the Company's capital redemption reserve. In addition, the nominal value of the Deferred Shares (which are non-voting save in respect of class rights), which the Directors consider to be effectively worthless due to the extremely restricted rights which the shares confer on their holders, was £2.88 million. Accordingly, as matters currently stand, the Company does not have distributable profits and is therefore unable to make any distributions to its shareholders or fund a purchase of its own shares out of distributable profits.

The Directors therefore propose, subject to the approval of holders of Shares and of the Court, to cancel all of the Deferred Shares as well as the Company's share premium account and capital redemption reserve and to reduce the nominal value of the Existing Ordinary Shares. The Directors then propose to apply the reserve arising to eliminate the Company's accumulated deficit on its profit and loss account and, indeed, to create distributable profits on the balance sheet of the Company of approximately £3.96 million. The Directors believe that, subject to the future performance of the Company, this should give the Company the ability to make distributions to Shareholders and/or buy back its own ordinary shares in the future if, as and when the Directors may consider that it is appropriate to do so, However, the Directors cannot give any guarantee either that the Company will make any distributions or purchases of own shares or as to the size of any distributions or purchases of own shares which may be made.

The Reduction of Capital does not involve any distribution or repayment of capital or share premium by the Company and will not reduce the underlying net assets of the Company.

 

CANCELLATION OF THE COMPANY'S DEFERRED SHARES, SHARE PREMIUM ACCOUNT AND CAPITAL REDEMPTION RESERVE AND REDUCTION OF THE NOMINAL VALUE OF THE EXISTING ORDINARY SHARES

The cancellation of the Company's Deferred Shares, share premium account and capital redemption reserve and the reduction of the nominal value of the Company's Existing Ordinary Shares from one penny to 0.1 pence will only become effective if (in the following order) (i) resolution 2 is approved by Shareholders at the General Meeting and the Reduction of Capital is approved by the holders of Deferred Shares, (ii) confirmation is given by the Court, and (iii) the Court order and a statement of capital are delivered to and registered by Companies House. 

As noted above, the cancellation of the Company's Deferred Shares, share premium account and capital redemption reserve and the reduction of the nominal value of the Company's Existing Ordinary Shares from one penny to 0.1 pence should enable the Directors to eliminate the current deficit on the Company's profit and loss account and create distributable profits. 

 

share options

The Company currently operates an Enterprise Management Incentive Scheme and an Unapproved Share Option Scheme for its directors and employees. As at the date of the Circular, the Company has the following outstanding options over 27,500,000 Existing Ordinary Shares, as follows:

 

Option holder

Date of grant

Plan under which option granted

Exercise period

Number of options granted and unexercised

Exercise price per share (pence)

Stephen Goodwin

5 February 2007

EMI

Between 2 and 10 years if target price achieved

5,000,000

1.50

 

5 May 2010

EMI

Between 2 and 10 years if target price achieved

2,500,000

1.25

Luke Jeffrey

5 February 2007

EMI

Between 2 and 10 years if target price achieved

1,000,000

1.50

 

5 November 2008

EMI

Between 2 and 10 years if target price achieved

1,000,000

1.00

 

5 May 2010

EMI

Between 2 and 10 years if target price achieved

1,000,000

1.25

Other employees

5 February 2007

EMI

Between 2 and 10 years if target price achieved

2,000,000

1.50

 

5 November 2008

EMI

Between 2 and 10 years if target price achieved

3,000,000

1.00

 

5 May 2010

EMI

Between 2 and 10 years if target price achieved

9,500,000

1.25

Barrie Whipp

5 May 2010

Unapproved

Between 5 May 2010 and 5 May 2020 (both dates inclusive) if target price achieved

2,500,000

1.25

The remuneration committee of the Company will consider what, if any, adjustments need to be made to the number of option shares and/or the exercise price following completion of the Reduction of Capital in accordance with the terms of the Enterprise Management Incentive Scheme and the Unapproved Share Option Scheme (as the case may be).

 

General Meeting AND APPROVAL BY THE HOLDERS OF THE DEFERRED SHARES

The cancellation of the Company's Deferred Shares, share premium account and capital redemption reserve and the reduction of the nominal value of the Company's Existing Ordinary Shares from one penny to 0.1 pence requires the approval of Shareholders by special resolution in general meeting as well as the approval of the holder of the Deferred Shares. 

A notice convening a General Meeting of the Company, to be held at the offices of Shipleys LLP at 10 Orange Street, Haymarket, London, WC2H 7DQ on 26 January 2016 at 11.30 a.m. and at which resolution 2 set out in the Notice of the General Meeting will be proposed, is set out at the end of the Circular. Resolution 2 to approve the Reduction of Capital will be proposed as a special resolution requiring a majority of not less than 75 per cent. of the votes cast.

In December 2015, the Company exercised its right under the Company's existing articles of association to transfer all of the Deferred Shares, without making any payment or obtaining the approval of the holders of the Deferred Shares, to one of the Directors, Mr Goodwin. Mr Goodwin, as the sole holder of the Deferred Shares, will give the requisite approval of the Reduction of Capital and the adoption of the New Articles at around the time of the General Meeting.

 

application to the court

If resolution 2 to be proposed at the General Meeting is approved, and assuming approval of the Reduction of Capital is also given by the holder of the Deferred Shares, the Board intends to make an application to the Court promptly following the General Meeting to confirm the Reduction of Capital. To this end, provisional dates have been obtained for hearing the Company's application. These dates are subject to change depending on the Court's timetable, but the present timetable provides for the final hearing of the Company's application to take place on 24 February 2016.

Prior to confirming the cancellation of the Deferred Shares, share premium account and capital redemption reserve and the reduction of the nominal value of the Company's Existing Ordinary Shares from one penny to 0.1 pence, the Court will need to be satisfied that the creditors of the Company at the Effective Date are not prejudiced by the same. The Company will put in place such form of creditor protection as is appropriate to satisfy the Court in this regard, which may include, amongst other things, the Company (i) seeking consent from certain creditors, and/or (ii) giving an undertaking to the Court to create a special, non-distributable reserve, with any such reserve to remain until the relevant creditors of the Company at the Effective Date who are not protected at that date by other means have been otherwise protected or discharged.

The precise form of creditor protection is a question for the Court and the Company will give such creditor protections as the Court requires and the Company's solicitors advise are appropriate. The Board reserves the right not to pursue an application for an order confirming the Reduction of Capital if it appears that the creditor protection which would be required by the Court would be unduly onerous or otherwise contrary to the interests of the Company.

 

effect of the reduction of capital

Subject to approval by Shareholders and the holder of the Deferred Shares, and to Court consent, the amounts resulting from the cancellation of the Company's Deferred Shares, share premium account and capital redemption reserve and the reduction of the nominal value of the Company's Existing Ordinary Shares from one penny to 0.1 pence will be credited to the Company's profit and loss account to create (subject to the Court's confirmation) distributable profits that the Company will be able to use when making any future distributions to Shareholders or purchases of own shares. 

The Reduction of Capital does not involve any distribution or repayment of capital or share premium by the Company and will not reduce the underlying net assets of the Company.

 

AUTHORITY FOR PURCHASE OF OWN SHARES

In order to facilitate Share Buy-Backs at a future date, the Board is seeking the authority of Shareholders to enable the Company to purchase New Ordinary Shares in the market in accordance with the Act. The terms of the proposed authority for such purchases by the Company are set out in full in resolution 3 as set out in the Notice of General Meeting. Save as may otherwise be permitted by the Act from time to time, any such Share Buy-Backs would be conditional upon the Company having sufficient distributable profits at the relevant time to fund such Share Buy-Backs. The Directors currently do not envisage that the Company would have such distributable profits unless the Reduction of Capital is implemented in full.

The authority sought from Shareholders for Share Buy-Backs will be limited to a maximum of 44,548,623 New Ordinary Shares (representing approximately 10 per cent. of the total issued ordinary share capital of the Company as at the date of the Circular). New Ordinary Shares so purchased may be cancelled or held as treasury shares. The authority will expire at the conclusion of the first annual general meeting falling three years from the passing of resolution 3 as set out in the Notice of General Meeting. The Directors may seek renewal of such authority at future annual general meetings of the Company, if they believe that this would be in the best interests of the Company.

The minimum price that can be paid for an ordinary share of the Company is 0.1 pence, which will be the nominal value of a New Ordinary Share following the Reduction of Capital. The maximum price that can be paid is 5 per cent. over the average of the middle market prices for an ordinary share of the Company, derived from the Daily Official List of the London Stock Exchange, for the five business days immediately before the day on which the New Ordinary Share is contracted to be purchased. The Directors intend to exercise this right only when, in light of the market conditions prevailing at the time and taking into account all relevant factors (for example, the effect on earnings per share), they believe that such purchases are in the best interests of the Company and Shareholders generally. The overall position of the Company will be taken into account before deciding upon this course of action. The decision as to whether any such New Ordinary Shares of the Company bought back will be cancelled or held in treasury will be made by the Directors on the same basis at the time of the purchase.

new articles of association

The Board proposes the adoption of the New Articles subject to the passing of resolution 1 at the General Meeting and the approval of the holder of the Deferred Shares to bring its articles into line with changes which were introduced by the Act. A copy of the proposed New Articles is available for inspection at the registered office of the Company during usual business hours on any business day up to and including the day of the General Meeting and will also be available for inspection at the General Meeting for at least 15 minutes prior to and during the meeting. Additionally the proposed New Articles are available for inspection on the Company's website at the following address: www.crimsontide.co.uk.

 

admission

Following the Reduction of Capital becoming effective, the New Ordinary Shares will be admitted to trading on AIM. It is expected that admission of the New Ordinary Shares to trading on AIM will take place on 25 February 2016. The ISIN number for the New Ordinary Shares will remain unchanged, and the Company does not propose to issue new share certificates to Shareholders as a result of the Reduction of Capital. The existing share certificates which have been issued to Shareholders in respect of their holdings of Existing Ordinary Shares will remain valid in respect of the New Ordinary Shares.

 

Recommendation

The Directors consider that the Resolutions are in the best interests of the Company and would promote the success of the Company for the benefit of its Shareholders as a whole. Accordingly, the Directors unanimously recommend that Shareholders vote in favour of the Resolutions to be proposed at the General Meeting as they intend to do in respect of their own beneficial shareholdings amounting, in aggregate, to 155,189,994 Existing Ordinary Shares, representing approximately 35 per cent. of the Company's existing issued ordinary share capital (excluding the 9,150,000 Existing Ordinary Shares in which Stephen Goodwin has an interest as a trustee which, however, he also intends to use to vote in favour of the Resolutions).

 

 

 

EXPECTED TIMETABLE OF PRINCIPAL EVENTS

 

Publication of the Circular

30 December 2015

 

 

Latest time and date for receipt of Forms of Proxy

11.30 a.m. on 24 January 2016

 

 

General Meeting

11.30 a.m. on 26 January 2016

 

 

Court hearing of application to confirm the Reduction of Capital

24 February 2016

 

 

Record Date for the Reduction of Capital

close of business on 24 February 2016

 

 

Effective Date of the Reduction of Capital

25 February 2016

 

 

Admission effective and dealings commence on AIM in the New Ordinary Shares

8.00 a.m. on 25 February 2016

 

 

 

General notes:

 

(1) The date of the Court hearing is subject, amongst other things, to change by the Court.

 

(2) The Effective Date is dependent upon, amongst other things, the date upon which the Court confirms the Reduction of Capital.

 

(3) Each of the times and dates set out above is based on current expectations and is subject to change. If any of the above times and/or dates is changed, the revised times and/or dates will be notified to Shareholders by announcement thorough a regulatory information service.

 

(4) All above references to times are to London times.

 

DEFINITIONS

 

The following definitions and terms apply throughout this announcement unless otherwise stated or the context requires otherwise:

 

"Act"

the Companies Act 2006;

"Circular"

the circular containing the Notice of General Meeting and background information which was mailed to Shareholders on 30 December 2015

"Crimson Tide" or "the Company"

Crimson Tide plc, a company incorporated and registered in England and Wales with registered number 00113845;

"Court"

the High Court of Justice of England and Wales;

"CREST"

the system for paperless settlement of trades and the holding of uncertificated shares administered through Euroclear UK & Ireland Limited in accordance with the Uncertificated Securities Regulations 2001 (SI 2001/3755) as amended from time to time;

"Deferred Shares"

deferred shares of 19 pence each in the capital of the Company;

"Directors" or "Board"

the board of directors of the Company as at the date of the Circular;

"Effective Date"

the date on which the Reduction of Capital becomes effective;

"Existing Ordinary Shares"

ordinary shares of one penny each in the capital of the Company;

"Form of Proxy"

the accompanying form of proxy for use in connection with the General Meeting;

"General Meeting"

the general meeting of the Company to be held at the offices of Shipleys LLP at 10 Orange Street, Haymarket, London, WC2H 7DQ on 26 January 2016 at 11.30 a.m., notice of which is set out at the end of the Circular;

"New Articles"

the new articles of association of the Company proposed to be adopted by the Company subject to the passing of resolution 1 at the General Meeting and to the approval of the holder of the Deferred Shares;

"New Ordinary Shares"

ordinary shares of 0.1 pence each in the capital of the Company;

"Notice of General Meeting"

the notice convening the General Meeting contained in the Circular;

"Reduction of Capital"

the proposed cancellation of the Deferred Shares and the Company's share premium account and capital redemption reserve and the proposed reduction of the nominal value of each Existing Ordinary Share from one penny to 0.1 pence under Part 17, Chapter 10 of the Act, as described in the Circular;

"Resolutions"

the special resolutions to be proposed at the General Meeting as set out in the Notice of General Meeting at the end of the Circular;

"Share Buy-Backs"

buy-backs by the Company of its own shares in accordance with the authority sought in accordance with resolution 3 as set out in the Notice of General Meeting;

"Shareholders"

the holders of Existing Ordinary Shares; and

"Shares"

Deferred Shares and/or Existing Ordinary Shares, as the case may be.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCTLBATMBATBPA
Date   Source Headline
23rd Jan 20247:00 amRNSTrading Update
28th Nov 20237:00 amRNSTrading Update
31st Oct 202311:45 amRNSResult of GM, Share Consolidation & TVR
10th Oct 20237:00 amRNSContract increases and extensions
6th Oct 20237:00 amRNSFurther re: Proposed Share Consolidation
5th Oct 20237:00 amRNSProposed Share Consolidation
26th Sep 20237:00 amRNSDirector dealing
25th Sep 20237:00 amRNSInterim Results
20th Sep 20237:00 amRNSContract Win
14th Sep 20237:00 amRNSStrengthened Operating Board
20th Jun 20234:20 pmRNSResult of AGM and Statement
31st May 20237:00 amRNSBoard changes
31st May 20237:00 amRNSPosting of Annual Report and Notice of AGM
10th May 20232:10 pmRNSDirectorate Change
4th May 20237:00 amRNSContract Win and Renewals
12th Apr 20237:00 amRNSPreliminary Results
5th Apr 20237:00 amRNSContract Win
1st Mar 20237:00 amRNSNotice of Results and Investor Presentation
7th Feb 20232:00 pmRNSHolding(s) in Company
6th Feb 20233:55 pmRNSHolding(s) in Company
1st Feb 20237:00 amRNSContract Win
18th Jan 20237:00 amRNSTrading Update
4th Jan 20235:00 pmRNSHolding(s) in Company
1st Dec 20227:00 amRNSDirector dealing
17th Nov 20227:00 amRNSSignificant contract expansion and extension
27th Sep 20227:00 amRNSInterim Results
25th Aug 20227:00 amRNSDirector Dealing
3rd Aug 20227:00 amRNSChange of Auditor
2nd Aug 20227:00 amRNSBoard Changes
25th Jul 20227:00 amRNSContract Win
19th Jul 20227:00 amRNSMultiyear contract win with major wholesaler
30th Jun 202211:27 amRNSResults of AGM & Statement
16th Jun 20224:30 pmRNSAnnual Report and Notice of AGM
7th Apr 20227:00 amRNSPreliminary Results
10th Feb 20227:00 amRNSContract Win and Strategic Partnership
3rd Feb 20227:00 amRNSTrading Update
7th Dec 20217:00 amRNSMaster Service Agreement with Compass Group
12th Nov 20217:00 amRNSDirectorate Change
11th Oct 202110:59 amRNSPDMR Dealing
28th Sep 20217:00 amRNSInterim Results
29th Jun 20213:08 pmRNSResult of AGM
16th Jun 20217:00 amRNSNorth America Appointment
4th Jun 20217:00 amRNSAnnual Report and Notice of AGM
4th May 20212:22 pmRNSTotal Voting Rights
28th Apr 202110:34 amRNSHolding(s) in Company
27th Apr 20217:00 amRNSHolding(s) in Company
26th Apr 20217:00 amRNSHolding(s) in Company
23rd Apr 20214:25 pmRNSHolding(s) in Company
23rd Apr 202110:37 amRNSPDMR Dealings
23rd Apr 202110:36 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.